Topic
Date published
21/08/2023
The ground-breaking efforts of a researcher from the University of Leicester in the field of testing non-adherence to antihypertensive medication have played a pivotal role in securing substantial funding support.
Dr Patrick Highton is set to receive a £722,478 grant from the National Institute of Health and Care Research (NIHR) and Department of Health and Social Care to investigate the acceptability of antihypertensive medication non-adherence testing in those with multiple long-term conditions from ethnic minority populations.
The grant will be issued to Dr Highton after he was successful in his NIHR Advanced Fellowship application – a programme to support individuals on their trajectory to become future leaders in health and social care research.
“I am deeply honoured to have been awarded the grant from the Department of Health and Social Care to further advance our research on the acceptability of antihypertensive medication non-adherence testing,” said Dr Highton.
He added: “This funding will enable us to delve deeper into understanding the unique challenges faced by individuals with multiple long-term conditions from ethnic minority populations and how best to support them to take their medications regularly.
“Our commitment to enhancing healthcare equity and improving outcomes remains steadfast, and this grant empowers us to continue making strides towards personalised, culturally sensitive interventions that can truly make a difference in the lives of those we serve.”
Dr Highton is a Research Fellow currently working for the NIHR Applied Research Collaboration (ARC) East Midlands, within the Diabetes Research Centre at the University of Leicester.